Kiora Pharmaceuticals Inc
KPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001372514
No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.
Other share classesKPHMW
Q1 2022 vs. Q4 2021
How the institutions holding Kiora Pharmaceuticals Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 13 | 16 | +3 |
| Shares | 804.9K | 831.4K | +26.6K (+3.3%) |
| Value | $1.22M | $517.0K | −$699.0K (−57.5%) |
New holders (5)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 93,619 | $58.0K | 0.00% |
| Ergoteles LLC | 17,800 | $11.0K | 0.00% |
| Goldman Sachs Group Inc | 13,275 | $8.00K | 0.00% |
| Susquehanna International Group, LLP | 11,330 | $7.00K | 0.00% |
| Citigroup Inc | 1,000 | $1.00K | 0.00% |
Sold out (2)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Jane Street Group, LLC | 31,232 | $47.0K |
| Bank of America Corp | 19 | $0 |